Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-4-8
pubmed:abstractText
Greater understanding of the cellular response in trastuzumab-treated patients will provide insight into the clinical management of patients.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
10
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2460-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15710948-Adult, pubmed-meshheading:15710948-Aged, pubmed-meshheading:15710948-Antibodies, Monoclonal, pubmed-meshheading:15710948-Antibodies, Monoclonal, Humanized, pubmed-meshheading:15710948-Antigens, Neoplasm, pubmed-meshheading:15710948-Antineoplastic Agents, pubmed-meshheading:15710948-Apoptosis, pubmed-meshheading:15710948-Breast Neoplasms, pubmed-meshheading:15710948-Cell Cycle, pubmed-meshheading:15710948-Cell Proliferation, pubmed-meshheading:15710948-Drug Administration Schedule, pubmed-meshheading:15710948-Female, pubmed-meshheading:15710948-Humans, pubmed-meshheading:15710948-Infusions, Intravenous, pubmed-meshheading:15710948-Middle Aged, pubmed-meshheading:15710948-Neoadjuvant Therapy, pubmed-meshheading:15710948-Prospective Studies, pubmed-meshheading:15710948-Receptor, erbB-2
pubmed:year
2005
pubmed:articleTitle
Neoadjuvant trastuzumab induces apoptosis in primary breast cancers.
pubmed:affiliation
Breast Center at Baylor College of Medicine/The Methodist Hospital, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't